Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals

Clinical and Vaccine Immunology

Volumn 21, Issue 3, 2014, Pages 360-365

  Park, Jae Keun ^a   Lee, Dong Hun ^a   Yuk, Seong Su ^a   Tseren Ochir, Erdene Ochir ^a   Kwon, Jung Hoon ^a   Noh, Jin Yong ^a   Kim, Byoung Yoon ^a   Choi, Soo Won ^a   Kang, Sang Moo ^b   Lee, Joong Bok ^a   Park, Seung Yong ^a   Choi, In Soo ^a   Song, Chang Seon ^a  

^a Konkuk University   (South Korea)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION TEST; IMMUNIZATION; IMMUNOGENICITY; MORTALITY; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROCONVERSION; SINGLE DRUG DOSE; VIRUS REPLICATION; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, MARKER; VACCINES, VIRUS-LIKE PARTICLE; VIRAL FUSION PROTEINS; VIRAL MATRIX PROTEINS; VIRAL VACCINES; VIRUS SHEDDING;

EID: 84896769763     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00636-13     Document Type: Article

References (27)

1. Saif YM, Barnes HJ. 2008. Diseases of poultry, 12th ed. Blackwell Publishing Professional, Ames, IA.
2. OIE. 2012. Chapter 2.3.14, Newcastle disease. InOIE terrestrial manual. OIE, Paris, France. http://www.oie.int/fileadmin/Home/fr/Health-standards/tahm/ 2.03.14-NEWCASTLE-DIS.pdf.
3. Roldão A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. 2010. Virus-like particles in vaccine development. Expert Rev. Vaccines 9:1149-1176. http://dx.doi.org/10.1586/erv.10.115.
4. Kang SM, Kim MC, Compans RW. 2012. Virus-like particles as universal influenza vaccines. Expert Rev. Vaccines 11:995-1007. http://dx.doi.org/10.1586/ erv.12.70.
5. Kushnir N, Streatfield SJ, Yusibov V. 2012. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31:58-83. http://dx.doi.org/10. 1016/j.vaccine.2012.10.083.
6. Noad R, Roy P. 2003. Virus-like particles as immunogens. Trends Microbiol. 11:438-444. http://dx.doi.org/10.1016/S0966-842X(03)00208-7. (Pubitemid 37101484)
7. Kang SM, Yoo DG, Kim MC, Song JM, Park MK, Eunju O, Quan FS, Akira S, Compans RW. 2011. MyD88plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J. Virol. 85: 11391-11400. http://dx.doi.org/10.1128/JVI.00080-11.
8. Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, Nabel GJ. 2010. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 16:334-338. http://dx.doi.org/10.1038/nm.2105.
9. Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, Yao Q. 2009. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J. Immunother. 32:118-128. http://dx.doi.org/10.1097/CJI.0b013e31818f13c4.
10. Jennings GT, Bachmann MF. 2008. The coming of age of virus-like particle vaccines. Biol. Chem. 389:521-536. (Pubitemid 351874198)
11. Morrison TG. 2010. Newcastle disease virus-like particles as a platform for the development of vaccines for human and agricultural pathogens. Future Virol. 5:545-554. http://dx.doi.org/10.2217/fvl.10.50.
12. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. 2006. Requirements for the assembly and release of Newcastle disease virus-like particles. J. Virol. 80:11062-11073. http://dx.doi.org/10.1128/JVI.00726-06. (Pubitemid 44706547)
13. McGinnes LW, Pantua H, Laliberte JP, Gravel KA, Jain S, Morrison TG. 2010. Assembly and biological and immunological properties of Newcastle disease virus-like particles. J. Virol. 84:4513-4523. http://dx.doi.org/10.1128/JVI. 01931-09.
14. Lee YJ, Sung HW, Choi JG, Lee EK, Yoon H, Kim JH, Song CS. 2008. Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins. J. Vet. Sci. 9:301-308. http://dx.doi.org/10.4142/jvs.2008.9.3.301.
15. Park JK, Lee DH, Youn HN, Kim MS, Lee YN, Yuk SS, Lim TH, Jang JH, Kwon JH, Kim BY, Kang SM, Seong BL, Lee JB, Park SY, Choi IS, Song CS. 2013. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respir. Viruses 7:340-348. http://dx.doi.org/10.1111/j.1750-2659.2012.00396.x.
16. Lee DH, Bae SW, Park JK, Kwon JH, Yuk SS, Song JM, Kang SM, Kwon YK, Kim HY, Song CS. 2013. Virus-like particle vaccine protects against H3N2 canine influenza virus in dog. Vaccine 31:3268-3273. http://dx.doi.org/10.1016/j. vaccine.2013.05.023.
17. Wise MG, Suarez DL, Seal BS, Pedersen JC, Senne DA, King DJ, Kapczynski DR, Spackman E. 2004. Development of a real-time reverse-transcription PCR for detection of Newcastle disease virus RNA in clinical samples. J. Clin. Microbiol. 42:329-338. http://dx.doi.org/10.1128/JCM.42.1.329-338.2004. (Pubitemid 38082740)
18. Fernandes F, Teixeira AP, Carinhas N, Carrondo MJT, Alves PM. 2013. Insect cells as a production platform of complex virus-like particles. Expert Rev. Vaccines 12:225-236. http://dx.doi.org/10.1586/erv.12.153.
19. Lee DH, Park JK, Lee YN, Song JM, Kang SM, Lee JB, Park SY, Choi IS, Song CS. 2011. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 29:4003-4007. http://dx.doi.org/10.1016/j.vaccine.2011.03.067.
20. Nam HM, Chae KS, Song YJ, Lee NH, Lee JB, Park SY, Song CS, Seo KH, Kang SM, Kim MC, Choi IS. 2013. Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch. Virol. 158: 1275-1285. http://dx.doi.org/10. 1007/s00705-013-1612-z.
21. Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C. 2009. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27:530-541. http://dx.doi.org/10.1016/j.vaccine.2008.11.011.
22. Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. 2011. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J. Infect. Dis. 204:987-995. http://dx.doi.org/10.1093/infdis/jir474.
23. Wang W, Chen X, Xue C, Du Y, Lv L, Liu Q, Li X, Ma Y, Shen H, Cao Y. 2012. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 30:7072-7077. http://dx.doi.org/10.1016/j.vaccine.2012.09.048.
24. Palya V, Kiss I, Tatar-Kis T, Mato T, Felfoldi B, Gardin Y. 2012. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Avian Dis. 56:282-287. http://dx.doi.org/10.1637/ 9935-091511-Reg.1.
25. Swayne DE. 2006. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann. N. Y. Acad. Sci. 1081:174-181. http://dx.doi.org/10.1196/annals.1373.021. (Pubitemid 44968771)
26. Kumar S, Nayak B, Collins PL, Samal SK. 2011. Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J. Virol. 85:6521-6534. http://dx.doi.org/10.1128/JVI.00367-11.
27. Meulemans G, Letellier C, Gonze M, Carlier MC, Burny A. 1988. Newcastle disease virus F glycoprotein expressed from a recombinant vaccinia virus vector protects chickens against live-virus challenge. Avian Pathol. 17:821-827. http://dx.doi.org/10.1080/03079458808436504.